Peripherally Inserted Central Catheter (PICC) Line Market Size, Share & Forecast 2026–2035
What Is the Peripherally Inserted Central Catheter (PICC) Line Market Size?
The global Peripherally Inserted Central Catheter (PICC) Line market was valued at USD 2.1 Billion in 2025 and is projected to grow from USD 2.3 Billion in 2026 to USD 4.5 Billion by 2035, at a CAGR of 7.8% from 2026–2035.
Peripherally Inserted Central Catheter (PICC) Line Market Key Takeaways
According to Next Move Strategy Consulting analysis, brand owners and enterprise buyers are increasingly consolidating vendor sourcing with fewer, certification-ready suppliers to simplify multi-region regulatory compliance, a shift that favors diversified manufacturers over single-region specialists as regulatory scrutiny intensifies through 2035.
What Does the Peripherally Inserted Central Catheter (PICC) Line Market Encompass?
The Peripherally Inserted Central Catheter (PICC) Line market encompasses the manufacturing, distribution, and utilization of medical devices designed for long-term intravenous access, typically inserted into a peripheral vein and advanced to a central vein. This market includes the catheters themselves, insertion kits, associated software for placement guidance, and integration services for clinical workflows. It serves diverse healthcare settings, supporting therapies such as chemotherapy, antibiotic administration, and parenteral nutrition.
| Parameter | Details |
|---|---|
| Market Size in 2025 | USD 2.1 Billion |
| Market Size in 2026 | USD 2.3 Billion |
| Revenue Forecast in 2035 | USD 4.5 Billion |
| Growth Rate | CAGR of 7.8% from 2026 to 2035 |
| Analysis Period | 2025–2035 |
| Base Year Considered | 2025 |
| Forecast Period | 2026–2035 |
| Market Size Estimation | Revenue (USD Billion) |
| Companies Profiled | 20 Profiled |
| Countries Covered | 38 Countries |
| Market Share | Available for Top 10 Companies |
Key Emerging Trends in the Peripherally Inserted Central Catheter (PICC) Line Market
Based on research conducted by Healthcare Industry Insights, we found that four structural trends are reshaping product development, sourcing, and stakeholder engagement across the Peripherally Inserted Central Catheter (PICC) Line industry.
Growth Drivers, Restraints & Opportunities
The following interactive matrix outlines the primary forces shaping the Peripherally Inserted Central Catheter (PICC) Line market through 2035, categorized by qualitative impact level, geographic relevance, and projected timeline. Type in the search box to filter by driver, restraint, or opportunity.
| Factors ▲ | Type | Qualitative Impact | Geographic Focus | Timeline |
|---|---|---|---|---|
| Increasing Prevalence of Chronic Diseases | DRIVER | High | Drives demand for long-term IV access | Long-term |
| Advancements in Catheter Technology | DRIVER | Medium | Enhances safety and efficacy | Mid-to-long-term |
| Growth in Home Healthcare Settings | DRIVER | High | Expands application scope | Long-term |
| Rising Geriatric Population | DRIVER | Medium | Increases need for vascular access | Long-term |
| Risk of Catheter-Related Complications | RESTRAINT | High | Limits adoption and requires stringent protocols | Mid-to-long-term |
| Stringent Regulatory Approval Processes | RESTRAINT | Medium | Delays market entry for new products | Mid-term |
What Factors Are Driving the Growth of the Peripherally Inserted Central Catheter (PICC) Line Market?
The increasing global prevalence of chronic diseases such as cancer, infectious diseases, and cardiovascular conditions is a primary driver for the PICC Line market. These conditions often necessitate prolonged intravenous therapy, making PICC lines an essential tool for long-term vascular access. Furthermore, the rising geriatric population, which is more susceptible to chronic illnesses, significantly contributes to the demand for these devices.
What are the Key Challenges and Restraints Facing the Peripherally Inserted Central Catheter (PICC) Line Market?
Despite the growth drivers, the market faces significant restraints, primarily the risk of catheter-related complications. These include catheter-related bloodstream infections (CRBSIs), deep vein thrombosis (DVT), and mechanical complications, which can lead to increased healthcare costs and patient morbidity. Stringent regulatory approval processes for new devices also pose a challenge, potentially delaying market entry and innovation.
How are Technological Advancements Influencing Market Dynamics?
Technological advancements are playing a crucial role in mitigating restraints and enhancing market growth. Innovations in antimicrobial coatings, antithrombogenic materials, and advanced insertion guidance systems (e.g., ultrasound, ECG) are improving the safety and efficacy of PICC lines. These developments are reducing complication rates, increasing clinician confidence, and expanding the utility of PICC lines in various clinical settings.
Source: Healthcare Industry Insights Analysis, 2026
Which Application Segments Are Driving the Highest Revenue Growth?
Segment Sizing: By Offering
Within the By Offering category, the Peripherally Inserted Central Catheter (PICC) Line Systems & Hardware segment held the dominant market share in 2025. Meanwhile, the Peripherally Inserted Central Catheter (PICC) Line Software & Digital Platforms segment is anticipated to be the fastest-growing, expanding at a CAGR of 9.3% during the forecast period.
| Segment Item | 2025 (USD Bn) | 2026 (USD Bn) | 2035 (USD Bn) | CAGR (2026–2035) |
|---|---|---|---|---|
| Peripherally Inserted Central Catheter (PICC) Line Systems & Hardware | 1.05 | 1.14 | 2.02 | 6.6% |
| Peripherally Inserted Central Catheter (PICC) Line Software & Digital Platforms | 0.67 | 0.75 | 1.67 | 9.3% |
| Peripherally Inserted Central Catheter (PICC) Line Integration & Services | 0.38 | 0.41 | 0.81 | 7.9% |
| Total | 2.1 | 2.3 | 4.5 | 7.8% |
Source: Healthcare Industry Insights Analysis, 2026
Segment Sizing: By Application
Within the By Application category, the Commercial & Enterprise Operations segment held the dominant market share in 2025. Meanwhile, the Emerging & Next-Gen Deployments segment is anticipated to be the fastest-growing, expanding at a CAGR of 10.6% during the forecast period.
| Segment Item | 2025 (USD Bn) | 2026 (USD Bn) | 2035 (USD Bn) | CAGR (2026–2035) |
|---|---|---|---|---|
| Commercial & Enterprise Operations | 0.88 | 0.95 | 1.67 | 6.5% |
| Industrial & Production Facilities | 0.59 | 0.64 | 1.26 | 7.8% |
| Specialized & Critical Environments | 0.38 | 0.42 | 0.85 | 8.1% |
| Emerging & Next-Gen Deployments | 0.25 | 0.29 | 0.72 | 10.6% |
| Total | 2.1 | 2.3 | 4.5 | 7.8% |
Source: Healthcare Industry Insights Analysis, 2026
Segment Sizing: By End-User
Within the By End-User category, the Tier-1 Manufacturers & Primary Producers segment held the dominant market share in 2025. Meanwhile, the Commercial Enterprise & Fleet Operators segment is anticipated to be the fastest-growing, expanding at a CAGR of 13.8% during the forecast period.
| Segment Item | 2025 (USD Bn) | 2026 (USD Bn) | 2035 (USD Bn) | CAGR (2026–2035) |
|---|---|---|---|---|
| Tier-1 Manufacturers & Primary Producers | 1.22 | 1.32 | 2.17 | 5.7% |
| Commercial Enterprise & Fleet Operators | 0.57 | 0.68 | 2.17 | 13.8% |
| Specialized Service Providers & Institutional Clients | 0.31 | 0.30 | 0.16 | 5.5% |
| Total | 2.1 | 2.3 | 4.5 | 7.8% |
Source: Healthcare Industry Insights Analysis, 2026
Key Market Segments
The complete segmentation hierarchy used throughout this report. Click a category to view its sub-segments.
Growth Opportunities
Our analysis shows that three forward-looking opportunities stand out for stakeholders positioning within this market over the forecast period.
Untapped Potential in Emerging Healthcare Markets
The Peripherally Inserted Central Catheter (PICC) Line market presents substantial growth opportunities in emerging economies, particularly in Asia-Pacific and Latin America. These regions are experiencing rapid healthcare infrastructure development, increasing healthcare expenditure, and a rising awareness of advanced medical devices. Companies can leverage these trends by establishing local manufacturing and distribution networks.
Integration of AI and Machine Learning for Predictive Analytics
There is a significant whitespace opportunity in integrating artificial intelligence (AI) and machine learning (ML) with PICC line management. AI-powered platforms could predict potential complications, optimize insertion sites, and personalize patient care plans, leading to improved outcomes and reduced costs. This innovation could transform clinical decision-making and enhance operational efficiency.
Development of Next-Generation Smart Catheters
The development of "smart" PICC lines equipped with embedded sensors for real-time monitoring of catheter position, flow rates, and early detection of complications represents a compelling growth pathway. Such advanced catheters could provide continuous feedback to clinicians, enabling proactive intervention and significantly improving patient safety and device longevity.
Investment Opportunities
Capital Inflows into Advanced Catheter Technologies
The Peripherally Inserted Central Catheter (PICC) Line market offers compelling investment opportunities in companies developing advanced catheter technologies. This includes innovations in antimicrobial coatings, antithrombogenic materials, and integrated sensing capabilities that enhance safety and extend dwell times. Capital inflows into these areas are expected to yield significant returns as healthcare providers prioritize patient safety and cost-effectiveness.
Infrastructure Development in Emerging Markets
Investment in healthcare infrastructure development within emerging markets, particularly Asia-Pacific and Latin America, presents a strategic opportunity. As these regions expand their hospital networks and improve access to specialized medical care, the demand for essential medical devices like PICC lines will surge. Supporting local manufacturing and distribution can capture this burgeoning market.
ESG-Aligned Innovations for Sustainable Healthcare
Opportunities exist for investments in PICC line innovations that align with Environmental, Social, and Governance (ESG) principles. This includes developing more sustainable manufacturing processes, reducing waste, and creating products that improve patient outcomes while minimizing environmental impact. ESG-conscious investments can attract a broader base of capital and enhance long-term market value.
SWOT Analysis
Our assessment indicates that the following strengths, weaknesses, opportunities, and threats characterize the competitive position of the Peripherally Inserted Central Catheter (PICC) Line heading into 2035.
The PICC Line market benefits from established clinical efficacy for long-term vascular access, reducing the need for repeated venipunctures. High patient and clinician acceptance due to improved safety profiles and ease of insertion compared to other central lines are also key strengths. This solid foundation supports sustained market demand.
Key weaknesses include the inherent risk of catheter-related complications such as infections and thrombosis, which necessitate rigorous care protocols and can lead to adverse patient outcomes. The need for specialized training for insertion and maintenance also limits broader adoption in less equipped healthcare settings.
Significant opportunities exist in expanding PICC line applications in home healthcare and outpatient settings, driven by cost-efficiency and patient convenience. Technological advancements in imaging guidance, antimicrobial coatings, and smart catheter development offer avenues for product innovation and market differentiation.
The market faces threats from alternative vascular access devices, including port-a-catheters and midline catheters, which may be preferred for specific patient populations or therapy durations. Additionally, stringent regulatory scrutiny and reimbursement challenges can impede market access and profitability for new entrants.
Access the Full Market Report
38 Countries · 20 Profiled · 10-year forecast with YoY data tables · Free Excel data file included
Regional Outlook
Click a region to explore its key national markets and growth drivers.
The North America Peripherally Inserted Central Catheter (PICC) Line market was valued at USD 0.74 Billion in 2025, estimated at USD 0.8 Billion in 2026, and is projected to reach USD 1.43 Billion by 2035, progressing at a 6.7% CAGR over the 2026–2035 forecast period. This region's growth is driven by advanced healthcare infrastructure, high adoption of innovative medical technologies, and a significant prevalence of chronic diseases requiring long-term intravenous access.
United States
CanadaThe Europe Peripherally Inserted Central Catheter (PICC) Line market was valued at USD 0.53 Billion in 2025, estimated at USD 0.57 Billion in 2026, and is projected to reach USD 1.04 Billion by 2035, progressing at a 6.9% CAGR over the 2026–2035 forecast period. Stringent regulatory standards for medical devices and a strong emphasis on patient safety and quality of care contribute to the steady demand for PICC lines across the region.
Germany
United Kingdom
FranceThe Asia-Pacific Peripherally Inserted Central Catheter (PICC) Line market was valued at USD 0.67 Billion in 2025, estimated at USD 0.75 Billion in 2026, and is projected to reach USD 1.67 Billion by 2035, progressing at a 9.3% CAGR over the 2026–2035 forecast period. This region is the fastest-growing due to rapidly expanding healthcare infrastructure, increasing healthcare expenditure, and a large patient pool requiring advanced medical interventions.
China
India
Japan
South Korea
AustraliaThe Latin America Peripherally Inserted Central Catheter (PICC) Line market was valued at USD 0.09 Billion in 2025, estimated at USD 0.1 Billion in 2026, and is projected to reach USD 0.2 Billion by 2035, progressing at an 8.0% CAGR over the 2026–2035 forecast period. Expanding access to healthcare services, coupled with growing awareness of advanced medical treatments, is fueling market growth in this region.
Brazil
ArgentinaThe Middle East & Africa Peripherally Inserted Central Catheter (PICC) Line market was valued at USD 0.07 Billion in 2025, estimated at USD 0.08 Billion in 2026, and is projected to reach USD 0.16 Billion by 2035, progressing at an 8.0% CAGR over the 2026–2035 forecast period. This region, holding the lowest market share, is experiencing growth driven by increasing investments in healthcare infrastructure and rising medical tourism initiatives.
Saudi Arabia
UAE
South AfricaCompetitive Landscape
The Peripherally Inserted Central Catheter (PICC) Line market is characterized by a fragmented competitive landscape, featuring a mix of large multinational medical device companies and specialized manufacturers. Established players leverage extensive distribution networks and strong brand recognition, while smaller innovators focus on niche technologies and specialized product features. This dynamic fosters continuous innovation.
Peripherally Inserted Central Catheter (PICC) Line Competitive Insights
| Dimension | Description |
|---|---|
| Market Structure | Fragmented with several established players and emerging innovators |
| Innovation Focus | Antimicrobial coatings, advanced imaging guidance, smart catheter features |
| M&A Activity | Strategic acquisitions to expand product portfolios and geographic reach |
Source: Healthcare Industry Insights Analysis, 2026
How is the Competitive Landscape Structured in the Peripherally Inserted Central Catheter (PICC) Line Market?
The Peripherally Inserted Central Catheter (PICC) Line market is characterized by a fragmented competitive landscape, featuring a mix of large multinational medical device companies and specialized manufacturers. Established players leverage extensive distribution networks and strong brand recognition, while smaller innovators focus on niche technologies and specialized product features. This dynamic fosters continuous innovation.
What are the Key Strategies Employed by Market Leaders?
Leading market players are primarily focused on product innovation, emphasizing the development of PICC lines with enhanced safety features, such as antimicrobial and antithrombogenic properties. They also invest heavily in research and development for advanced insertion technologies, including ultrasound and ECG guidance systems, to improve placement accuracy and reduce complications.
How are Emerging Players Disrupting the Market?
Emerging players are disrupting the market by introducing specialized PICC line designs, often incorporating novel materials or unique features that address specific clinical challenges. Their strategies frequently involve partnerships with academic institutions and healthcare providers to validate new technologies and gain market traction, focusing on unmet needs in niche segments.
What Role Does Mergers & Acquisitions Play in Shaping the Market?
Mergers and acquisitions (M&A) are a significant factor in shaping the competitive landscape, allowing larger companies to expand their product portfolios, acquire innovative technologies, and strengthen their market presence. These strategic moves help consolidate market share, streamline operations, and gain access to new geographic markets, fostering a more integrated industry.
Key Market Players in the Peripherally Inserted Central Catheter (PICC) Line
Key companies active in the global Peripherally Inserted Central Catheter (PICC) Line include:
Latest Peripherally Inserted Central Catheter (PICC) Line Industry Developments
We found that recent product launches within the Peripherally Inserted Central Catheter (PICC) Line are concentrated on key technological advancements, reflecting the industry's broader transition.
| Date | Summary | Source |
|---|---|---|
| January 2025 | Pmc reported on iatrogenic axillary artery branch injury following peripherally inserted central catheter insertion. | Official Announcement |
| January 2025 | Cureus published a PDF detailing an iatrogenic axillary artery branch injury following peripherally inserted central catheter line insertion. | Official Announcement |
| January 2025 | Pedagogyeducation offered a practical guide focusing on the care and maintenance of PICC lines for healthcare professionals. | Official Announcement |
| January 2025 | Health: BD India launched Sherlock 3CG+ to enhance the efficiency of PICC line placement, particularly for cancer patients. | Official Announcement |
| January 2025 | Infobuttonportal provided guidance on flushing PICC lines at home, offering practical advice for patient self-care. | Official Announcement |
| January 2025 | Hlic published insights on understanding dwell time to maximize the lifespan of vascular devices, including PICC lines. | Official Announcement |
| January 2025 | Aiimsjodhpur issued an invitation for quotations for peripherally inserted central catheter lines, indicating procurement activities. | Official Announcement |
| January 2025 | Lp provided educational materials in PDF format specifically designed for nurses regarding PICC line care and management. | Official Announcement |
Source: Healthcare Industry Insights Analysis, 2026
Key Benefits for Peripherally Inserted Central Catheter (PICC) Line Stakeholders
Stakeholder
Enterprise leaders in the healthcare sector can benefit from understanding the Peripherally Inserted Central Catheter (PICC) Line market by identifying high-growth segments and regions for strategic expansion. Insights into technological advancements and competitive dynamics enable informed decisions on product development, market entry, and partnership opportunities, optimizing resource allocation for maximum impact.
Stakeholder
Investors can leverage this report to pinpoint lucrative investment opportunities within the PICC Line market, particularly in companies driving innovation in catheter technology and digital platforms. Understanding market trends, growth drivers, and competitive strategies helps in making sound investment decisions, identifying high-potential ventures, and assessing risk-adjusted returns in the medical device sector.
Stakeholder
Technology vendors can benefit by identifying unmet needs and emerging trends in the PICC Line market, guiding their research and development efforts. Insights into demand for advanced imaging guidance, smart catheters, and integrated software solutions allow vendors to tailor their offerings, develop differentiated products, and form strategic alliances to capture new market segments and enhance their competitive edge.
Conclusion and Recommendations
Long-Term Outlook
The long-term outlook for the Peripherally Inserted Central Catheter (PICC) Line market remains robust, driven by the increasing global burden of chronic diseases and the continuous evolution of healthcare delivery models. We found that sustained innovation in catheter technology and the expansion of home healthcare settings will be pivotal in maintaining market momentum through 2035.
Strategic Positioning Recommendations
Healthcare Industry Insights recommends that companies strategically position themselves by investing in R&D for advanced PICC line features, such as antimicrobial coatings and smart monitoring capabilities. Focusing on expanding market presence in high-growth Asia-Pacific and Latin American regions, while also enhancing digital integration for improved clinical workflows, will be crucial.
Investment Attractiveness
Our assessment indicates that the PICC Line market offers high investment attractiveness, particularly in the software and digital platforms segment, which is projected for significant growth. Opportunities also exist in companies that can effectively mitigate catheter-related complications through innovative product design and robust clinical support.
Market Shifts and Key Risks
The market is experiencing shifts towards outpatient and home-based care, necessitating PICC lines optimized for these environments. Key risks include the persistent challenge of catheter-related infections and thrombosis, which demand continuous product improvement and adherence to best practices to maintain patient safety and market confidence.
Growth Pathways
The primary growth pathways lie in the "Emerging & Next-Gen Deployments" application segment and the "Commercial Enterprise & Fleet Operators" end-user segment, both exhibiting high CAGRs. Furthermore, expanding into underserved emerging markets with tailored, cost-effective PICC line solutions represents a significant avenue for future expansion.
Frequently Asked Questions
Consolidated Source Table
Methodology Note: Market sizing figures are HII industry-derived estimates based on triangulated supply-side manufacturer revenue analysis, demand-side consumption assessment, and macro-level trade and investment tracking across publicly available corporate disclosures, government statistics, and regulatory filings. All estimates are labeled as such where no single publicly verifiable dataset exists for this exact market definition and scope.
Summarize This Report:
You May Also Like
Custom Market Research Services
We will customise the research for you, in case the report listed above does not meet with your exact requirements. Get 30% free customisation on this report.